|
Re: A lot of expectations...???
|
2
|
Resverlogix Corp.
|
Dec 16, 2016 02:12PM
|
|
Re: MD&A out
|
2
|
Resverlogix Corp.
|
Dec 14, 2018 01:55PM
|
|
Re: Need An Explanation
|
2
|
Zenith Epigenetics
|
May 17, 2016 05:10PM
|
|
AZ gets approval for Farxiga.
|
2
|
Resverlogix Corp.
|
Oct 21, 2019 07:18AM
|
|
Re: New article from EHJ
|
2
|
Resverlogix Corp.
|
Jan 30, 2018 10:37AM
|
|
Re: Apabetalone for Long Covid
|
2
|
Resverlogix Corp.
|
Jul 26, 2024 10:17AM
|
|
Re: Does the Zenith AGM
|
2
|
Resverlogix Corp.
|
Oct 16, 2024 01:17PM
|
|
Re: Big disconnect between the chart for RVX.TO and for RVXCF.....
|
2
|
Resverlogix Corp.
|
Apr 17, 2019 03:04PM
|
|
Re: Wow! What’s with the panic attack?
|
2
|
Resverlogix Corp.
|
Dec 12, 2017 04:03PM
|
|
Re: If financing is coming....
|
2
|
Resverlogix Corp.
|
May 01, 2018 11:06AM
|
|
Re: Short interest drops 395
|
2
|
Resverlogix Corp.
|
Feb 22, 2018 08:27AM
|
|
Re: Licensing Deal
|
2
|
Resverlogix Corp.
|
Feb 27, 2017 04:08PM
|
|
Re: Tree Shaking?
|
2
|
Resverlogix Corp.
|
Mar 20, 2017 12:41PM
|
|
Re: ACC 2019?
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 11:19AM
|
|
Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 04:42PM
|
|
Re: Options
|
2
|
Resverlogix Corp.
|
Oct 23, 2019 10:44AM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 22, 2024 08:06PM
|
|
Re: We Need The Futility Analysis
|
2
|
Resverlogix Corp.
|
Feb 07, 2018 10:59PM
|
|
Re: SP 52 week low
|
2
|
Resverlogix Corp.
|
Oct 05, 2022 01:54PM
|
|
Re: Heavier than normal trading on the OTC for RVXCF
|
2
|
Resverlogix Corp.
|
Mar 16, 2017 05:19AM
|
